DHR
equitynet sellingDanaher Corp · NEW YORK STOCK EXCHANGE, INC.
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy DHR with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Financials
As each period's own 10-K or 10-Q reported it
At the $219.81 close on Oct 9, 2026, against 702.9M shares and the balance sheet at Jun 26, 2026; earnings, sales and cash flow over the four quarters to Jun 26, 2026. A ratio is left out where its denominator is not positive. Fair value is the company's own median P/E, price to sales and price to free cash flow at its last ten fiscal year ends, applied to its trailing figures, the middle of the three: its valuation against its own past, not against its growth or its rivals.
| Line item | FY 2016 Dec 31, 2016 | FY 2017 Dec 31, 2017 | FY 2018 Dec 31, 2018 | FY 2019 Dec 31, 2019 | FY 2020 Dec 31, 2020 | FY 2021 Dec 31, 2021 | FY 2022 Dec 31, 2022 | FY 2023 Dec 31, 2023 | FY 2024 Dec 31, 2024 | FY 2025 Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.9B | $18.3B | $19.9B | $17.9B | $22.3B | $29.5B | $31.5B | $23.9B | $23.9B | $24.6B |
| Gross margin | 55.3% | 55.6% | 55.8% | 55.7% | 56.0% | 61.0% | 60.2% | 58.7% | 59.5% | 59.1% |
| Operating income | $2.8B | $3B | $3.4B | $3.3B | $4.2B | $7.5B | $8.7B | $5.2B | $4.9B | $4.7B |
| Operating margin | 16.3% | 16.5% | 17.1% | 18.3% | 19.0% | 25.4% | 27.6% | 21.8% | 20.4% | 19.1% |
| Net income | $2.6B | $2.5B | $2.7B | $3B | $3.6B | $6.4B | $7.2B | $4.8B | $3.9B | $3.6B |
| Net margin | 15.1% | 13.6% | 13.3% | 16.8% | 16.4% | 21.8% | 22.9% | 19.9% | 16.3% | 14.7% |
| EPS (diluted) | $3.65 | $3.53 | $3.74 | $4.05 | $4.89 | $8.61 | $9.66 | $6.38 | $5.29 | $5.05 |
| Operating cash flow | $3.5B | $3.5B | $4B | $4B | $6.2B | $8.4B | $8.5B | $7.2B | $6.7B | $6.4B |
| Capital spending | $589.6M | $619.6M | $655.7M | $635.5M | $791M | $1.3B | $1.2B | $1.4B | $1.4B | $1.2B |
| Free cash flow | $2.9B | $2.9B | $3.4B | $3.3B | $5.4B | $7.1B | $7.4B | $5.8B | $5.3B | $5.3B |
| Buybacks | — | — | — | — | — | — | $0 | $0 | $6B | $3.1B |
| Dividends paid | $399.8M | $378.3M | $433.4M | $526.7M | $615M | $742M | $818M | $821M | $768M | $878M |
| Cash | $963.7M | $630.3M | $787.8M | $19.9B | $6B | $2.6B | $6B | $5.9B | $2.1B | $4.6B |
| Debt | $12.3B | $10.5B | $9.7B | $21.7B | $21.2B | $22.2B | $19.7B | $18.4B | $16B | $18.4B |
| Shareholders' equity | $23B | $26.4B | $28.2B | $30.3B | $39.8B | $45.2B | $50.1B | $53.5B | $49.5B | $52.5B |
| Shares outstanding | 692.2M | 696.6M | 701.5M | 695.5M | 711M | 715M | 728.3M | 739.2M | 719.1M | 706.9M |
Figures come from the company's XBRL filings as the SEC publishes them. Quarters are worked out from year-to-date figures, and a fourth quarter is the year less its first nine months, which is why it has no EPS: per-share figures do not subtract. Earlier years are on today's share basis where a split has happened since. A later restatement is not mixed into a year it was never applied to, so where a 10-K restated the year before — a business sold, say — that year's fourth quarter is left blank rather than worked out across two bases. A dash means the company did not report that line under a standard tag for that period. Every filing on EDGAR.
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 8.97M | +7.5% | 1.8 |
| Sep 15, 2026 | 8.34M | -13.4% | 2.7 |
| Aug 31, 2026 | 9.64M | +9.8% | 2.8 |
| Aug 14, 2026 | 8.78M | -27.3% | 2.6 |
| Jul 31, 2026 | 12.07M | +19.6% | 1.4 |
| Jul 15, 2026 | 10.1M | -7.0% | 2.7 |
| Jun 30, 2026 | 10.86M | -5.5% | 2.4 |
| Jun 15, 2026 | 11.49M | +23.7% | 2.9 |
Largest fails to deliver, the last year
37 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Dec 18, 2025 | 295.58K | $65.8M |
| Jun 4, 2026 | 81.35K | $14.5M |
| Jun 26, 2026 | 39.07K | $7.5M |
| Oct 21, 2025 | 14.69K | $3.1M |
| Aug 3, 2026 | 9.44K | $1.8M |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- DANAHER CORPORATION$200K
Health Issues, Tariff (miscellaneous tariff bills), Environment/Superfund
2nd Quarter (Apr 1 - June 30) 2026
- DANAHER CORPORATION$190K
Health Issues, Tariff (miscellaneous tariff bills), Environment/Superfund
1st Quarter (Jan 1 - Mar 31) 2026
- AKIN GUMP STRAUSS HAUER & FELD$60K
Trade (domestic/foreign)
1st Quarter (Jan 1 - Mar 31) 2026
- AKIN GUMP STRAUSS HAUER & FELD$60K
Trade (domestic/foreign)
2nd Quarter (Apr 1 - June 30) 2026
- FULCRUM PUBLIC AFFAIRS LLC$50K
Health Issues
2nd Quarter (Apr 1 - June 30) 2026
- FULCRUM PUBLIC AFFAIRS LLC$50K
Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
- LEWIS-BURKE ASSOCIATES, LLC$36K
Health Issues
2nd Quarter (Apr 1 - June 30) 2026
- DENTONS US LLP—
1st Quarter (Jan 1 - Mar 31) 2026
Federal contracts
Largest awards of the last two years
- Department of Health and Human Services$80.2M
CEPHEID · from Jul 23, 2021
- Department of Health and Human Services$72.1M
GLOBAL LIFE SCIENCES SOLUTIONS USA LLC · from Aug 1, 2023
- Department of Health and Human Services$13.4M
AB SCIEX LLC · from Jun 8, 2021
- Department of Veterans Affairs$9.3M
CEPHEID · from Mar 20, 2024
- Department of Veterans Affairs$3.8M
CEPHEID · from Oct 1, 2022
- Department of Veterans Affairs$3.3M
CEPHEID · from Jan 25, 2023
More on DHR
Who traded it
Most active first
Every disclosure
69 in total, newest first
Follow Danaher Corp (DHR) by email
New trades in Danaher Corp (DHR) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.